MedDataX Logo

Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65

NCT ID: NCT05414929

Last Updated: 2022-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-04

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV risk factors of patients included in the study will be taken into consideration (vaccination, smoking, number of partners, date of last screening, etc.).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Self-sampling for HPV Screening

NCT07273383

HPV Cervical Cancers
ACTIVE_NOT_RECRUITING NA

Acceptability of Self-sampling for Cervical Cancer Screening

NCT05314907

HPV-Related Cervical Carcinoma Self-sampling Cervical Cancer Screening
UNKNOWN NA

Acceptability of HPV-self Sampling

NCT03137563

Cervical Cancer
COMPLETED

HPV Self-sampling in the General Population

NCT06749847

Cervical Cancer
RECRUITING NA

Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening

NCT05243888

Cancer Screening Test
ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV Infection Cervical Cancer Screening

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HPV self-sampling group

Group Type EXPERIMENTAL

HPV self-sampling

Intervention Type DIAGNOSTIC_TEST

HPV self-sampling (Cobas Uniswab)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HPV self-sampling

HPV self-sampling (Cobas Uniswab)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Speak and understand French without help

* Have internet access (for completing forms)
* Have a mailing address

Exclusion Criteria

* Known positive HPV status • Have already had a hysterectomy
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Sherbrooke

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Josianne Pare

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Ruel-Laliberte J, Jacob-Wagner M, Bestman-Smith J, Pare J. Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study. J Obstet Gynaecol Can. 2023 Apr;45(4):261-266. doi: 10.1016/j.jogc.2023.02.012. Epub 2023 Mar 3.

Reference Type DERIVED
PMID: 36870436 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-4535

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 COMPLETED PHASE3
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
NCT02255084 COMPLETED NA
Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015 UNKNOWN NA
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 COMPLETED EARLY_PHASE1
Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner
NCT02749110 COMPLETED NA
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
NCT00977392 COMPLETED
Acceptability of Human Papillomavirus Self-sampling in Women Living With HIV
NCT05026047 UNKNOWN NA
Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3
NCT02651883 COMPLETED NA
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
NCT03012932 COMPLETED NA
Emergency Room HPV Self-Sampling Study (ACT NOW)
NCT06178549 COMPLETED NA
Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care
NCT02698423 COMPLETED NA
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
NCT03813576 UNKNOWN NA
Offering Cervical Cancer Screening to Older Women
NCT04114968 RECRUITING
Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer
NCT03856684 COMPLETED NA
Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders
NCT04909281 COMPLETED
HPV Testing for Cervical Cancer Screening Study
NCT00461760 COMPLETED NA
Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women
NCT03183700 UNKNOWN NA
HPV Self-sampling for Underscreened Latinas
NCT06439706 COMPLETED NA
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers
NCT01051895 ACTIVE_NOT_RECRUITING NA
Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments
NCT04591977 TERMINATED NA
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
NCT06371118 RECRUITING NA
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 COMPLETED
Cervical And Self-Sample In Screening Study
NCT02397252 COMPLETED NA
Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil
NCT03713697 COMPLETED NA
Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma
NCT05458869 COMPLETED